A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors

NCT04659096 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ION537

Sponsor

Ionis Pharmaceuticals, Inc.

Collaborators

[object Object]